Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,082Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M4,082EPS $0Operating Margin %-570.3F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0.4Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M15.8ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IBBJohn Griffin 2009-06-30 Sold Out -0.8%$63.11 - $72.98
($67.01)
$ 276.24312%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONDON PHILIP GPortfolio Manager 2013-11-26Buy3,000$11.752250.98 view
GABELLI MARIO JControl Person of Adviser 2013-11-26Sell35,600$21.471186.63 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$15.761652.79 view
FRIEDRICH ROMAN IIITrustee 2013-11-25Buy100$21.481186.03 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$18.191418.64 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy135$17.81451.91 view
CONDON PHILIP GPortfolio Manager 2013-11-22Buy8,500$11.82241.02 view
Dammeyer Rodney FDirector 2013-11-22Buy31,940$6.164384.42 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy107$18.061429.57 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy113$18.091427.03 view

Press Releases about IBB :

    Quarterly/Annual Reports about IBB:

      News about IBB:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Value in biotech: Pro Oct 22 2014
      Is This Your Portfolio? Oct 20 2014
      Is it time to “Score On Defense?” Oct 15 2014
      Biotech ETFs Aren’t Waving the White Flag…Yet Oct 15 2014
      [video] CDC enhances Ebola screening Oct 08 2014
      [video] CDC guidance on Ebola remains Oct 08 2014
      [video] Outlook for experimental Ebola drugs Oct 08 2014
      [video] Ebola & experimental drugs Oct 08 2014
      Ebola & experimental drugs Oct 08 2014
      Tekmira CEO says being a biotech is like being in ‘shark-infested water’ Oct 08 2014
      Market's heading lower-Here's what to do: Pros Oct 07 2014
      [video] The Ebola fighters Oct 07 2014
      The Ebola fighters Oct 07 2014
      [video] Future of genetic testing Oct 07 2014
      Future of genetic testing Oct 07 2014
      The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First... Oct 03 2014
      Must-read: Why low rates lead to capital misallocation Sep 30 2014
      The Complete Guide to Biotech ETFs Sep 30 2014
      [video] Q4 momentum Sep 30 2014
      Q4 momentum Sep 30 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK